ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
volvoman
|
100 |
28K |
11 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
100
|
28K
|
11
|
|
ASX - By Stock
|
PLS |
Re:
Ann: Pilbara Minerals Signs Offtake Agreement with Yahua
|
|
volvoman
|
71 |
50K |
47 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
71
|
50K
|
47
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
volvoman
|
549 |
179K |
3 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
179K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
volvoman
|
549 |
179K |
6 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
179K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
volvoman
|
549 |
179K |
5 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
179K
|
5
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Outstanding Gold Results Drive New Program at Yundamindra
|
|
volvoman
|
24 |
7.9K |
9 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
24
|
7.9K
|
9
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Outstanding Gold Results Drive New Program at Yundamindra
|
|
volvoman
|
24 |
7.9K |
2 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
24
|
7.9K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Preliminary Final Report
|
|
volvoman
|
10 |
6.1K |
3 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
10
|
6.1K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
volvoman
|
664 |
271K |
20 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
664
|
271K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
volvoman
|
317 |
83K |
7 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
317
|
83K
|
7
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
2 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
43K
|
21M
|
2
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
45 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
43K
|
21M
|
45
|
|
ASX - By Stock
|
MNB |
Re:
Ann: Suspension from Quotation
|
|
volvoman
|
181 |
43K |
6 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
181
|
43K
|
6
|
|
ASX - By Stock
|
PLS |
Re:
Overnight
|
|
volvoman
|
5 |
3.3K |
8 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
5
|
3.3K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
volvoman
|
1.4K |
365K |
9 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
9
|
|
ASX - By Stock
|
RNU Graphite |
Re:
General Discussions
|
|
volvoman
|
30K |
15M |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
30K
|
15M
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
volvoman
|
152 |
47K |
10 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
47K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
volvoman
|
152 |
47K |
23 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
47K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
volvoman
|
152 |
47K |
7 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
47K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
volvoman
|
209 |
51K |
4 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
51K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
volvoman
|
209 |
51K |
3 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
51K
|
3
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Push Forward with Exploration at Yundamindra
|
|
volvoman
|
20 |
8.6K |
6 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
20
|
8.6K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
volvoman
|
209 |
51K |
12 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
51K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
volvoman
|
209 |
51K |
5 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
209
|
51K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
volvoman
|
209 |
51K |
22 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
209
|
51K
|
22
|
|
ASX - By Stock
|
AVR |
Re:
price control
|
|
volvoman
|
13 |
6.7K |
3 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
13
|
6.7K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
volvoman
|
323 |
77K |
6 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
323
|
77K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
volvoman
|
323 |
77K |
8 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
323
|
77K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
volvoman
|
1.4K |
365K |
5 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Forms World-Class Scientific Advisory Board
|
|
volvoman
|
11 |
4.2K |
24 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
11
|
4.2K
|
24
|
|
ASX - By Stock
|
AVZ |
Re:
Litigation Timelines
|
|
volvoman
|
871 |
362K |
4 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
871
|
362K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
volvoman
|
197 |
53K |
9 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
197
|
53K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
volvoman
|
197 |
53K |
14 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
197
|
53K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
volvoman
|
197 |
53K |
16 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
197
|
53K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
volvoman
|
272 |
103K |
37 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
272
|
103K
|
37
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
9.9K |
2.9M |
6 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
9.9K
|
2.9M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
9.9K |
2.9M |
24 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
9.9K
|
2.9M
|
24
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
volvoman
|
1.4K |
365K |
6 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
volvoman
|
1.4K |
365K |
15 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
15
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
volvoman
|
48 |
13K |
0 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
48
|
13K
|
0
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
volvoman
|
48 |
13K |
2 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
48
|
13K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
volvoman
|
1.4K |
365K |
16 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
16
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Manono Project Mineral Resource increases 47% to 842Mt
|
|
volvoman
|
307 |
154K |
1 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
307
|
154K
|
1
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Push Forward with Exploration at Yundamindra
|
|
volvoman
|
20 |
8.6K |
4 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
20
|
8.6K
|
4
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
23 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
43K
|
21M
|
23
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Manono Project Mineral Resource increases 47% to 842Mt
|
|
volvoman
|
307 |
154K |
11 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
307
|
154K
|
11
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Push Forward with Exploration at Yundamindra
|
|
volvoman
|
20 |
8.6K |
7 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
20
|
8.6K
|
7
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Manono Project Mineral Resource increases 47% to 842Mt
|
|
volvoman
|
307 |
154K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
307
|
154K
|
1
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Quarterly Activities Report
|
|
volvoman
|
5 |
1.7K |
8 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
5
|
1.7K
|
8
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Manono Project Mineral Resource increases 47% to 842Mt
|
|
volvoman
|
307 |
154K |
16 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
307
|
154K
|
16
|
|